Magnesium Lithospermate B 丹参酸 B 镁,98.29%
产品编号:Bellancom-126415| CAS NO:122021-74-3| 分子式:C36H28MgO16| 分子量:740.90
Magnesium Lithospermate B 是从 Salviae miltiorrhizae 中提取的咖啡酸四聚体的衍生物。Magnesium Lithospermate B 被广泛用于心血管疾病的研究,并且可以防止葡萄糖引起的细胞内氧化损伤。Magnesium Lithospermate B 还能够抑制神经炎症并减轻神经变性。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Magnesium Lithospermate B 丹参酸 B 镁
产品介绍 | Magnesium Lithospermate B 是从 Salviae miltiorrhizae 中提取的咖啡酸四聚体的衍生物。Magnesium Lithospermate B 被广泛用于心血管疾病的研究,并且可以防止葡萄糖引起的细胞内氧化损伤。Magnesium Lithospermate B 还能够抑制神经炎症并减轻神经变性。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Magnesium Lithospermate B, a derivative of caffeic acid tetramer, and is extracted from Salviae miltiorrhizae. Magnesium Lithospermate B is widely used for the research of cardiovascular diseases, and it can protect against glucose-induced intracellular oxidative damage. Magnesium Lithospermate B also suppresses neuroinflammation and attenuates neurodegeneration. | ||||||||||||||||
体外研究 |
Magnesium Lithospermate B (20-60 μg/ml; 24 h) decreases LDH activity in the cultured supernatant, increases SOD activity in cardiomyocytes, reduces intracellular ROS and MDA levels, and significantly suppresses cardiomyocytes apoptosis. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Magnesium Lithospermate B (2-8 mg/kg; p.o. once daily for 16 d) reduces the renal damage of oxidative stress through reduction of reactive oxygen species in old rats. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
体内研究 |
Magnesium Lithospermate B (2-8 mg/kg; p.o. once daily for 16 d) reduces the renal damage of oxidative stress through reduction of reactive oxygen species in old rats. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (134.97 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
参考文献 |
|

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存